ResMed | Stammkapital

Aktienkurs
256.17
Täglich Wechseln
-2.74 -1.06%
Monatlich
1.18%
Jährlich
10.04%
Q1 Prognose
244.72




Stammkapital Veränderung Datum
Ansell USD 1.03B 305.2M 2024-06
AtriCure USD 49.7M 10K 2025-09
Baxter International USD 514.28M 168.72M 2025-12
Cochlear AUD 1.18B 19.2M 2024-12
Cooper Companies USD 198.81M 9K 2025-09
CSL USD 576M 19M 2024-12
Dexcom USD 384.8M 5.2M 2025-12
Edwards Lifesciences USD 580.7M 7.2M 2025-09
Fisher Paykel Healthcare NZD 587.25M 1.35M 2025-12
Globus Medical USD 135.05M 134.92M 2025-06
Haemonetics USD 46.83M 82K 2025-12
Hologic USD 222.57M 350K 2025-09
Idexx Laboratories USD 79.85M 154K 2025-12
Inogen USD 23K 0 2023-12
Insulet USD 70.35M 1000 2025-12
Integra LifeSciences USD 77.92M 77M 2025-06
Intuitive Surgical USD 354.5M 3.98M 2025-12
Masimo USD 53.1M 1.2M 2025-09
Medtronic USD 1.28B 116K 2025-09
Philips EUR 951.29M 310K 2025-12
Ramsay Health Care AUD 2.27B 19.6M 2024-12
ResMed USD 145.97M 25K 2025-12
Sigma Healthcare AUD 11.5B 9.93B 2025-12
Sonic Healthcare AUD 4.15B 467K 2024-12
Steris USD 98.15M 344K 2025-12
Teleflex USD 44.19M 482K 2025-06
Thermo Fisher Scientific USD 375.71M 1.9M 2025-12


ResMed Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.